Vascular Biogenics Ltd. (VBLT)
(Delayed Data from NSDQ)
$1.28 USD
+0.01 (0.79%)
Updated May 3, 2019 03:59 PM ET
After-Market: $1.28 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For VBLT
-
Vascular Biogenics: Q2 Earnings Snapshot
-
VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
-
Vascular Biogenics: Q1 Earnings Snapshot
-
VBL Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
-
Vascular Biogenics: Q3 Earnings Snapshot
-
Vascular Biogenics (VBLT) Reports Q3 Loss, Tops Revenue Estimates
-
VBL Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates
-
Vascular Biogenics: Q2 Earnings Snapshot
-
Analysts Estimate Vascular Biogenics (VBLT) to Report a Decline in Earnings: What to Look Out for
-
Vascular Biogenics (VBLT) Reports Q1 Loss, Misses Revenue Estimates
-
Vascular Biogenics (VBLT) Reports Q4 Loss, Lags Revenue Estimates
-
Vascular Biogenics (VBLT) Reports Q3 Loss, Lags Revenue Estimates
-
Will Vascular Biogenics (VBLT) Report Negative Q3 Earnings? What You Should Know
-
Vascular Biogenics (VBLT) Reports Q2 Loss, Lags Revenue Estimates
-
Will Vascular Biogenics (VBLT) Report Negative Q2 Earnings? What You Should Know
-
Vascular Biogenics (VBLT) Reports Q1 Loss, Lags Revenue Estimates
-
Vascular Biogenics (VBLT) Reports Q4 Loss, Tops Revenue Estimates
-
Vascular Biogenics (VBLT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
Vascular Biogenics (VBLT) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
-
Vascular Biogenics (VBLT) Reports Q3 Loss, Tops Revenue Estimates
-
Vascular Biogenics (VBLT) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: Vascular Biogenics (VBLT) Q2 Earnings Expected to Decline
-
Vascular Biogenics (VBLT) Reports Q1 Loss, Tops Revenue Estimates
-
Earnings Preview: Vascular Biogenics (VBLT) Q1 Earnings Expected to Decline